Axonics Modulation Technologies

+$0.81 (+1.14%) As of 2:12 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell AXNX and other ETFs, options, and stocks.

About AXNX

Axonics, Inc. is a medical device company, which engages in developing and commercializing of novel implantable sacral neuromodulation (SNM) devices to treat patients with bladder and bowel dysfunction. Its product Bulkamid, which is a urethral bulking agent used to treat stress urinary incontinence in women.

CEO
Raymond Wayne Cohen
Employees
416
Headquarters
Irvine, California
Founded
2012

AXNX Key Statistics

Market Cap
3.32B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
346.59K
High Today
$72.39
Low Today
$69.33
Open Price
$71.24
Volume
26.31K
52 Week High
$79.81
52 Week Low
$41.13

AXNX Earnings

-$0.67
-$0.45
-$0.22
$0.00
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Available Nov 4, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure